Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Common Equity (2022 - 2025)

Medinotec's Common Equity history spans 4 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Common Equity rose 94.64% year-over-year to $5.5 million; the TTM value through Nov 2025 reached $5.5 million, up 94.64%, while the annual FY2025 figure was $4.3 million, 97.07% up from the prior year.
  • Common Equity reached $5.5 million in Q4 2025 per MDNC's latest filing, up from $4.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $5.5 million in Q4 2025 to a low of -$729826.0 in Q3 2022.
  • Average Common Equity over 4 years is $2.7 million, with a median of $2.6 million recorded in 2022.
  • The largest YoY upside for Common Equity was 643.86% in 2023 against a maximum downside of 19.7% in 2023.
  • A 4-year view of Common Equity shows it stood at $2.6 million in 2022, then fell by 19.7% to $2.1 million in 2023, then skyrocketed by 36.17% to $2.8 million in 2024, then skyrocketed by 94.64% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Common Equity are $5.5 million (Q4 2025), $4.8 million (Q3 2025), and $4.4 million (Q2 2025).